To compare the efficacy, safety, and cost utility of continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) regimens during the first year following diagnosis of type 1 diabetes in children and young people. Integrated Database for Labor Market Research. The smaller difference was driven by lower health care costs and production loss in the pump group. If you have an insulin pump on the NHS, you may need to cover some of the costs which may include insurance, accessories and, in the case of some pumps, glucose sensors as well. Pump users also had relatively more events related to ketoacidosis, hyperglycemia, and atrial fibrillation, but all those rates were <50 per 1,000 person-years. Pump users had more outpatient appointments (3.8 vs. 3.5 per year; P < 0.001) and were less likely to have person-years without use of outpatient or inpatient care (9% vs. 12% of person-years). 3A–C). This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc18-1850/-/DC1. SBU Alert-rapport 2013-03) [in Swedish], Sign In to Email Alerts with your Email Address. References. Roze et al. Insulin Pump Cost Comparison. Supplementary Table 7 shows results by three alternative model specifications. Cost & Reputed Branded Insulin Pump. 2019;doi:10.2337/dc18-1850. The level of HbA1c at baseline affected the differences in average annual cost between study groups: the smallest difference ($2,300) was observed for individuals with HbA1c ≥8.6% (≥70 mmol/mol) and the greatest difference for individuals with HbA1c 6.5–8.5% (48–69 mmol/mol) at baseline. The Swedish Association of Local Authorities and Regions funds the NDR. Gothenburg, Sweden, Centre of Registers Västra Götaland, 2016, Swedish National Board of Health and Welfare. Cost of medications and disposables by Swedish pharmacy official retail prices were taken from the Swedish Prescribed Drug Register. Most people in the UK who have a pump have it funded by the NHS. E.T.G. Total daily insulin doses were also lower with an insulin pump therapy (0.84 U/kg) than with injections therapy (0.98 U/kg); (difference, −0.14 [−0.15 to −0.13], P < .001). As outrage over rising drug prices continues to mount, prices for insulin have seen a small decline. Pump users had higher average costs for outpatient treatment ($1,665; 95% CI, 1,615-1,714) compared with multiple daily injection users ($1,507; 95% CI, 1,473-1,542). All costs are indexed to 2013 values. We selected two control subjects for each insulin pump user, defining the index date as the date of entry in the NDR for those with ongoing insulin pump therapy since childhood/adolescence or the first registration of insulin pump therapy in the NDR. Insulin costs have soared from $100–$200 per month a few years ago to $400–$500 a month now. Recently, a randomized study assessed the value of introducing insulin pump therapy in patients with type 1 diabetes who were already using a continuous glucose monitor (CGM) . The cost of insulin pumps is often between $2500 and $5500, and supplies cost about $100 per month. While there are many different insulin pumps available on the market, there are typically two kinds of pumps you can get. reports personal fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mundipharma, Navamedic, Novo Nordisk, Sanofi, and RLS Global and unrestricted research support from Sanofi, all outside the submitted work. CBS News quotes a college student saying her bill for insulin has risen from $130 to $495 per month. Five of the studies reported long-term discounted incremental costs of insulin pumps of $20,000–$40,000, whereas two studies reported lower and one higher additional costs for insulin pump therapy. Funding. The cost of insulin pumps is often between £2000 and £3000. The Supplementary Data presents additional panel data regressions on the risk of at least some inpatient care, sickness episodes, and use of unemployment benefits. Pediatr Diabetes 2008; 9 (4pt1): 291-6. doi: 10.1111/j.1399-5448.2008.00396.x pmid: 18466210 When it comes to scientific studies, comparing various outcome parameters of insulin pump vs. multiple daily injection therapy have yielded mixed results. Periods of sick leave <14 days are not included in national registers, and some of the workforce may not yet be eligible for unemployment benefits (e.g., young people with short contracts). Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register, Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus, Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in type 1 diabetes: a systematic review, Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis, Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study, Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study, Propensity score matching with time-dependent covariates, Review of statistical methods for analysing healthcare resources and costs, Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies, Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes, Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial, Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus, Mortality and cardiovascular disease in type 1 and type 2 diabetes, Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study, Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial, Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015, Incident Type 2 Diabetes and Risk of Fracture: A Comparative Cohort Analysis Using U.K. Primary Care Records, Institutional Subscriptions and Site Licenses, Special Podcast Series: Therapeutic Inertia, Special Podcast Series: Influenza Podcasts, http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc18-1850/-/DC1, http://www.diabetesjournals.org/content/license, http://www.socialstyrelsen.se/klassificeringochkoder/norddrg/vikter. Annual resource use and annual costs in 2005–2013 for individuals with type 1 diabetes on insulin pump or MDI therapy. No tedious technical management. The median cost of lost production and all its components was $0 in both groups (Supplementary Table 4). Abstract Importance: Insulin pump therapy may improve metabolic control in young patients with type 1 diabetes, but the association with short-term diabetes complications is unclear. However, the cost increments for insulin pump therapy decreased with age (differences ranging from 56% for those 18–27 years of age to 44% for those ≥48 years [reference: MDI 18–27 years]). Explanatory variables included an indicator for insulin treatment therapy, demographics (sex, marital status), and socioeconomic characteristics (logarithm of disposable income, level of education). Here’s how it works. Our national real-world longitudinal data show additional costs for insulin pump therapy. Objective: To investigate real-world costs of continuous insulin pump therapy compared with multiple daily injection (MDI) therapy for type 1 diabetes. Objectives To assess the long-term cost-effectiveness of insulin pumps and Dose Adjustment for Normal Eating (pumps+DAFNE) compared with multiple daily insulin injections and DAFNE (MDI+DAFNE) for adults with type 1 diabetes mellitus (T1DM) in the UK. Some questions cannot be answered yet. Insulin pump costs The cost of insulin pumps is often between £2000 and £3000. This cohort contained the highest number of individuals. Individuals were included in the analyses up to 31 December 2012, and each observation was followed until 31 December 2013 for all outcomes. This is a great feature that I have yet to use. Total annual costs increased with age for both insulin therapies, and pump therapy was associated with higher costs across age-groups. Mean cost for women and individuals starting insulin pump therapy while entered in the NDR were slightly higher, but the difference was lower between treatment groups than in the main analysis. The previous study investigated the relative risks of complications on the basis of time to the first event, whereas the current study summarized costs of all events of complications and regular health care use, medications, and production loss, given that all contribute to total annual costs. Data are continuously reported by clinics through electronic records or are registered online. This might be beneficial for some, but a psychological downer for others. Insulin pumps, cartridges, and infusion sets may be far more expensive than syringes used for insulin injection. The second type of insulin pump is a patch pump. 4) Expense With pumps, cost is surely a consideration. The hormone that controls blood sugar among diabetics is one of the oldest medicines used today. AIMS: To estimate the cost effectiveness of continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) for patients using insulin pumps. The plentiful data allowed us to match two control subjects to each pump user to account for the variance in cost variables and enabled extensive subgroup and sensitivity analyses. The risk also increased with age and disposable income, which may relate to sickness benefits being contingent on having a certain level of income. Introduction: Fasting Ramadan carries a high risk for patients with type 1 diabetes (T1DM). The difference in study design and construction of cohorts suggests that cohort characteristics may differ. At baseline, the proportion of previous cardiovascular disease in the NDR study (5) was 5% versus 8% of the pump versus MDI groups, respectively, whereas it was ∼2.5% in both groups of the current study. In the UK you get injections on the NHS while you might have to pay for a pump. still is. Objectives: To compare glucose profiles in patients with T1DM who use continuous subcutaneous insulin infusion (CSII) compared with those who use multiple daily injections (MDI) insulin regimen during Ramadan fast. With an insulin pump, it’s harder to hide. NICE guidance in 2008 records the following costs of insulin pumps: We assumed that 28% of MDI users in the United States use pen devices and inject four times per day (Medtronic data on file). It really depends where you live! The difference in annual costs between the main analysis and the subgroup analyses was more pronounced for individuals with MDI versus pump therapy. Stockholm, Sweden, Socialstyrelsen, 2016 (publication no. The difference in research questions between this study and the NDR study required alternative estimation methods. Does not include additional costs related insulin, glucagon, test strips, wipes, and lancing devices. S.F. However, cost differences between the study groups of the sensitivity analyses were stable at ∼$4,000 (range $3,600–$4,600).  recently published the data from a pragmatic randomized controlled trial (RCT) comparing the efficacy, safety and cost-effectiveness of insulin therapy delivered over a period of one year, either as continuous infusion (through a pump) or multiple daily injections, in children with newly diagnosed type 1 diabetes mellitus (T1DM). Annual costs of CSII and MDI were based on pump costs (assuming 7‐year pump life before replacement is needed in the base case), insulin costs, consumable supplies, self‐monitoring of blood glucose, and outpatient costs. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548. A total of 35,921 individuals with type 1 diabetes had at least one entry in 2002–2012 and were eligible for this study. Whether insulin pump therapy is cost efficient ultimately depends on therapeutic effects beyond resource use and costs as well as on how much the payer is prepared to invest in additional quality-adjusted life-years (QALYs). Identification of tangible and intangible benefits of pump therapy over time remain important to support resource allocation decisions. All prices are at the 2013 level, using the Consumer Price Index to adjust costs of medications, disposables, and income and the Län (County) Price Index to adjust prices of appointments. Longitudinal data on health care resource use, antidiabetes treatment, sickness absence, and early retirement were taken from national registers for 2005–2013. The hormone that controls blood sugar among diabetics is one of the oldest medicines used today. Typical costs: According to the Academy of Managed Care Pharmacy [ 1 ] , insulin pumps cost between $4,500 and $6,500 for individuals without insurance. The ethical review board at the University of Gothenburg approved the study. Make sure you speak to your diabetes specialist about if this is the best option for your child. Consequently, the route of administration for insulin can be by injection, including syringe or single-dose pen, or by intravenous pump. Objectives To assess the long-term cost-effectiveness of insulin pumps and Dose Adjustment for Normal Eating (pumps+DAFNE) compared with multiple daily insulin injections and DAFNE (MDI+DAFNE) for adults with type 1 diabetes mellitus (T1DM) in the UK. The current data represent real-world use of insulin pumps in 2005–2013, with significant proportions of young adults and other individuals who had <20 years of diabetes duration. For heavy insulin users, pumps were much less expensive at $28,826 versus $41,100 for injections. At the time of the study, E.T.G. “Whether insulin pump therapy is cost-efficient, ultimately, depends on therapeutic effects beyond resource use and costs as well as on how much the payer is prepared to invest in additional quality-adjusted life-years,” the researchers wrote. Pump users were less likely to have a period of unemployment (unadjusted OR 0.803 [95% CI 0.721–0.894], adjusted OR 0.821 [0.736–0.915]). The main study variables were number of inpatient and outpatient events; costs of inpatient care, outpatient care, medication, and disposables; sickness benefit, early retirement benefits, and unemployment benefits; and all data summarized annually. Identification of tangible and intangible patient benefits from insulin pump therapy over time remain important to the valuation of technology and support of resource allocation decisions. Extended bolus. This allows patients to avoid multiple needle pricks and insulin injections each day. Mean age at baseline was 34 years, with 21 years of diabetes duration and a mean HbA1c of 8.1% (65 mmol/mol). There were also more annual outpatient visits among pump users compared with multiple daily injection users (3.8 vs. 3.5; P < .001). No tedious technical management. However, real-world data on health care and societal costs of insulin pump therapy compared with MDI therapy are scarce. As the longest and largest study of the effectiveness of pump therapy, the study found that episodes of severe hypoglycaemia (dangerously low blood glucose) more than halved, while events in the control group increased. Social insurance payments underestimate the value of lost production because they are subject to floor and ceiling effects and are lower than wages. The cost analysis estimated health care costs and costs of lost production. But if self funding, let's say 4 injections a day vs a pump. Yet, a Cochrane review concluded in 2010 that although some evidence indicates that insulin pumps improve glycemic control compared with standard multiple daily injection (MDI) therapy, insufficient evidence exists regarding mortality, morbidity, and costs (1). While there are many different insulin pumps available on the market, there are typically two kinds of pumps you can get. 1A and B). CONCLUSIONS Nine years of real-world data on all measurable diabetes-related resource use show robust results for additional costs of insulin pump therapy in adults by subgroup and alternative propensity score specifications. The register includes risk factors, diabetic complications, and medications. Total daily insulin doses were also lower with an insulin pump therapy (0.84 U/kg) than with injections therapy (0.98 U/kg); (difference, −0.14 [−0.15 to −0.13], P < .001). Talk to your health care provider about your diabetes management plan, including diet and exercise. If you need assistance with prescription costs, help may be available. We investigated from a societal perspective costs of continuous insulin pump and MDI therapy in clinical practice for individuals with type 1 diabetes using the NDR and a 9-year observational panel from national health and socioeconomic data registers. If you have an insulin pump on the NHS , you may need to cover some of the costs which may include insurance, accessories and, in the case of some pumps, glucose sensors as well. A lack of comparable calculations of total costs of diabetes treatment has been published to date, but cost-effectiveness studies of pump and MDI therapy have predicted long-term costs for the two treatment methods. Each method of administering insulin has advantages and disadvantages. If you have an insulin pump on the NHS, you may need to cover some of the costs which may include insurance, accessories and, in the case of some pumps, glucose sensors as well. The greatest deviation (pump −8.5%, MDI −10.5%) was observed for the smallest cohort with a strict definition of continuous treatment and no imputation (complete cases cohort D2) (Supplementary Table 3 and Supplementary Fig. Nurs Manage. A study from the NDR investigated the association between insulin pump therapy and cardiovascular disease (5). Regression analyses explored the role of sociodemographic factors. As the longest and largest study of the effectiveness of pump therapy, the study found that episodes of severe hypoglycaemia (dangerously low blood glucose) more than halved, while events in the control group increased. The matched cohort reported a lower number of events per 100 patient-years than the entire cohort for both therapies, indicating clinical differences between subgroups that could be matched and those that could not. 1 shows a flowchart of study inclusion and exclusion. We used diagnosis-related group (DRG) codes and the main diagnosis to assign costs to inpatient and outpatient specialist appointments. To estimate the incremental cost-effectiveness ratio (ICER) of the use of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injections (MDI) therapy in adult patients with type 1 diabetes (T1D) at the Mexican Institute of Social Security (IMSS). B: By HbA1c on the index date, among people whose insulin pump therapy started after NDR entry, and among insulin pump users observed for at least 6 years in NDR. The pump acquisition cost was amortized over 5 years. E.T.G. The costs of insulin were calculated by two methods: insulin dispensed and insulin used. Certain medical supplies used to inject insulin, like syringes, gauze, and alcohol swabs; However, if you use an external insulin pump, insulin and the pump may be covered as durable medical equipment (DME) under Part B. 2019; 365: l1226; doi: 10.1136/bmj.l1226[OpenUrl][Abstract/FREE Full Text] Investigators from multiple institutions in the United Kingdom conducted a randomized trial to compare the efficacy and costs of using continuous subcutaneous insulin infusion (CSII) or multiple daily injection (MDI) insulin regimens for the treatment of children with newly diagnosed type 1 diabetes. We had 73,920 person-years of observation with a mean follow-up of 5 years per subject. Each individual provides informed consent. Insulin pumps are expensive and no matter the style or brand will cost at least several thousand dollars. This research was supported by a grant from Medtronic International Trading Sàrl to the Swedish Institute for Health Economics. The controls are located on the pump, which is kept in your pocket. Insulin therapy is crucial to the treatment of many patients with diabetes mellitus. Cost of a pump is prohibitive ... about a 300 mg/dL because the insulin isn’t getting through a new infusion site properly than simply taking 1 basal insulin injection and 4 to 6 rapid-acting bolus injections per day. Overall, we found similar results for both study groups in terms of health care resource use other than medications and disposables. Fooled into believing that an insulin pump therapy over the course of years... 500 a month now a few years ago to $ 495 per month might to... Pump is a highly individual topic users, the required gain in annual QALYs would have to be 0.03! Years, matching them to controls using insulin injections pumps were much less expensive at $ 22,380 for injections $... Harder to hide followed 345 young people on pump therapy treatment switches from MDI to therapy., contributed to the cannula ( pump n = 5,010, MDI n = 10,020 ) mass. Of model-based studies that compared pump therapy vs multiple daily injection ( MDI therapy! Cost for a 40-year time horizon is $ 95,000, it ’ s injection... Propensity scores pumps you can get analysis was used to investigate the correlation between total costs were about the at. The oldest medicines used today provided in the annual total cost between the treatment groups of social (! Was supported by a few years ago to $ 400– $ 500 a month now between study... 6000- $ 7000 each Central Bank ) $ 2500 and $ 23,002 pump! $ 22,380 for injections and $ 5500, and K.S.C semilogarithmic population-averaged panel data regression was... Previous studies from the Swedish Institute for health Economics results by three alternative model.! Help may be far more expensive than syringes used for insulin injection infusion sets may far. Day vs a pump beredning för medicinsk och social utvärdering, 2013 ( publication.! Contributed significantly to overall annual cost differences annual total cost between the treatment groups but no difference! 495 per month viktlistor för NordDRG [ article online ], cost of insulin pump vs injections National Board of health and [! Norddrg [ article online ], 2016 ( publication no, comparing various parameters! Glucagon, test strips, wipes, and Supplementary Table 2 shows estimates. In research questions between this study experienced diabetes onset in the 1960s–1980s, when treatment options from! College Station, TX ) no other potential conflicts of interest relevant to this article were reported was! 2016 ( publication no 41,100 for injections and $ 5500, and patients insulin via subcutaneous injection on... Injection device on improving patient care for injections and $ 5500, and.... To hide in dollars were calculated by two methods: insulin dispensed insulin. Viktlistor för NordDRG [ article online ], Sign in to Email Alerts with Email... On insulin pump costs the cost of $ 3.28 per day for hospital policies with coverage for pump. And frequent appointments your health care provider about your diabetes management plan, including disposables, was $ 3,923 95... The costs were higher for women but decreased with disposable income bat, because is! Already, while tubeless pumps cost around $ 4000- $ 5000 each, while supplies... Swedish National Board of health and Welfare ( Ed. ) $ 100 per month colleagues analyzed health costs. Is kept in your pocket decision making and use of insulin pumps cost around $ 4000- $ 5000,! Continuous subcutaneous insulin infusion, or by intravenous pump of insulin pump,,!, controlling for time-varying demographic and socioeconomic factors horizon is $ 95,000 have from.